Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New foot-and-mouth vaccine marks a significant milestone
Scientists hope the vaccine will address the current shortfall in availability.

Vaccine less reliant on cold-chain transport and storage

A new affordable vaccine to protect livestock against several serotypes of foot-and-mouth-disease (FMD) has been granted for development by The Pirbright Institute.

Researchers say the new vaccine is more stable than existing FMD vaccines and less reliant on a cold-chain during vaccine distribution - characteristics that give the vaccine greater potential to relieve the burden placed on regions where the disease is endemic.

The vaccine is the result of a long-standing collaboration between Pirbright, the University of Oxford, Diamond Light Source, the University of Reading and MSD Animal Health, who will now be taking the technology into development.


It also marks a significant milestone in years of research to develop a new synthetic vaccine.

“We are proud and excited that our research has resulted in a vaccine that is undergoing commercial development and will have a major impact on the health and wellbeing of those people whose livelihoods have been most severely affected by this devastating disease,” said Professor Bryan Charleston, director of The Pirbright Institute. 


“The vaccine’s properties allow for a greater degree of flexibility during production, storage and transportation, which will result in a more affordable solution and therefore better access to those living in areas such as Asia and Africa.”


The vaccine is comprised of small, synthetic protein shells called ‘virus-like particles’ (VLPs). These VLPs mimic the outer shell of FMDV, stimulating an immune response.

Unlike inactivated FMD vaccines, the VLPs do not require high containment facilities for production and have been designed to remain stable up to temperatures of 56 degrees celsius, therefore reducing reliance on cold-chain transport and storage.

It is hoped that these factors combined will revolutionise vaccination in areas of Africa and Asia, where the disease continues to circulate.

Defra chief veterinary officer Christine Middlemiss said: “This is a major milestone in tackling the foot-and-mouth disease in the developing countries where it is endemic.

“The increased robustness of this new vaccine has the potential to not only protect livestock but to transform the lives of people whose livelihoods have previously been threatened by this disease. Many people have worked for years to get to this point, and I am delighted to see the vaccine receive its commercial licence.”

 

Become a member or log in to add this story to your CPD history

Pair of endangered Amur leopard cubs born at Colchester Zoo

News Story 1
 Keepers at Colchester Zoo are hailing the arrival of a pair of critically endangered Amur leopard cubs.

The cubs were born to first-time parents Esra and Crispin on the 9 September. This is the first time the Zoo has bred Amur leopard cubs on-site.

Amur leopards originate from the Russian Far East and north-east China. In the wild they are threatened by climate change, habitat loss, deforestation and the illegal wildlife trade.

The cubs are said to be “looking well” and are expected to emerge from their den in a few weeks.  

Click here for more...
News Shorts
RCVS names Professor John Innes as chair of Fellowship Board

Professor John Innes has been elected chair of the 2019 RCVS Fellowship Board, replacing Professor Nick Bacon who comes to the end of his three-year term.


Professor Innes will be responsible for making sure the Fellowship progresses towards fulfilling its strategic goals, determining its ongoing strategy and objectives, and reporting to the RCVS Advancement of the Professions Committee on developments within the Fellowship.